Author: C1_Admin
New Jersey Announces Open Application Period for Medical Marijuana Licenses
Friends, Government officials in New Jersey recently opened the application period to add up to six additional medical marijuana dispensaries. The state plans to allow two each in North, Central, and South Jersey. Applicants or interested parties must attend a mandatory meeting at the Trenton headquarters for the Department of Health on Thursday, August 9. […]
July 20, 2018
Marijuana Business Licencing Process
For the licensing process, there are going to be state and local requirements. Depending on which class of marijuana you want to apply for, either medical or retail, you might need to go to the local government or the state first, but you’re always going to need generally the same documents. Those include an operating […]
July 17, 2018
Kelly Rosenberg Appointed to MED Working Group
Friends, Kelly Rosenberg, Senior Attorney at McAllister Garfield, P.C., has been appointed to participate in the Marijuana Enforcement Division’s Legislation Implementation Work Group related to the MED’s rulemaking. The Work Group will focus on rules to implement SB18-187 – Waste Recycling, HB18-1280 – Court Appointees, HB18-1389 – Centralized Distribution, and HB18-1381 – Vertical Integration. The […]
July 9, 2018
Opportunities for Hemp Growers
Here at McAllister Garfield, we get questions from hemp growers about the opportunities for hemp other than CBD. There are over 25,000 uses for hemp, and CBD is just one. Some of its more industrial uses include textiles, such as clothing, construction materials, food and animal bedding, just to name a few. There […]
July 9, 2018
Dangers of Making Health Claims in CBD Product Labelling
One question that we get a lot about industrial hemp and CBD products is how to navigate the requirements of The Food and Drug Administration. One area where you can definitely get into trouble with the FDA is by making health claims about a CBD product on your label. The FDA has sent warning letters […]
June 28, 2018
FDA Approves CBD Medication for the Treatment of Epilepsy
This past Monday, the FDA approved Epidiolex, a marijuana derived CBD medication produced by GW Pharmaceuticals. Epidiolex – an oral solution for the treatment of certain forms of epilepsy – is the first FDA-approved drug that contains a purified derivative from marijuana. In approving Epidiolex, the FDA confirms that marijuana has medical benefits and applications, […]
June 28, 2018
Recent Colorado Bills Related to Cannabis and Hemp
This past legislative session, the Colorado General Assembly passed numerous bills related to cannabis and hemp. The following list highlights key points from a few bills that are of practical significance to operators. Please note the MED will conduct a rulemaking in the fall to implement many of these new laws and the following summary is just the highlights of each bill […]
June 22, 2018
How to Navigate FDA Labeling Requirements for CBD and Hemp Products
One question that we get a lot about CBD and hemp is how to navigate FDA labeling requirements. This is a confusing topic because the FDA hasn’t provided any clear guidance about what is allowed. They’ve only posted some opinions about what is not allowed. The one thing to really avoid in this area is […]
June 15, 2018
Legal Issues Facing CBD and Hemp
There is a lot of opportunity in the hemp field and there’s a lot of activity in the space as well. CBD and hemp are derived from the cannabis plant, yet are not psychoactive. They have less than 3/10ths of a percent THC. The federal government has passed some laws that protect CBD […]
June 11, 2018